Li Minxia, Li Yuehong
Int J Clin Pharmacol Ther. 2020 Nov;58(11):595-600. doi: 10.5414/CP203737.
Very few studies have investigated vitamin D deficiency of Chinese chronic kidney disease (CKD) patients. Our main aims were to measure 25(OH)D levels and to explore the possible correlated factors contributing to vitamin D deficiency.
207 patients who came from north China and were not receiving vitamin D supplementation were included in this study from February 2013 to April 2015. We collected blood samples to determine levels of serum creatinine (Scr), blood urea nitrogen (BUN), uric acid (UA), serum phosphate (P) and calcium (Ca), intact parathyroid hormone (iPTH), albumin (ALB), as well as urinary protein within 24 hours (24hUPr). Total 25(OH)D was measured via electrochemiluminescence immunoassay. Vitamin D deficiency should be defined as a 25(OH)D < 15 ng/mL.
Of the 207 patients, only 20.3% had a circulating 25(OH)D level > 15 ng/mL. The concentrations of 25(OH)D were 11.73 ± 6.75 ng/mL, 10.44 ± 6.03 ng/mL, 10.05 ± 5.57 ng/mL, 9.10 ± 5.00 ng/mL, 7.13 ± 3.99 ng/mL (p < 0.001) according to estimated glomerular filtration rate (eGFR) (89 - 60, 59 - 45, 44 - 30, 29 - 15, < 15 mL/min/1.73m). The prevalence of 25(OH)D deficiency was significantly high in each group (70.1%, 70.8%, 76.5%, 81.6%, 91.4%, p < 0.001). 25(OH)D concentration decreased with the decline of renal function. The difference of 25(OH)D levels between the 24hUPr ≥ 3.5 g group and the 24hUPr < 3.5 g group was statistically significant. Multivariate linear regression analysis showed that 25(OH)D concentration was associated with 24hUPr and serum Ca. The 25(OH)D concentration was lower, and the prevalence of 25(OH)D deficiency was higher in diabetes mellitus (DM) patients compared with patients without DM.
This study shows a high prevalence of 25(OH)D deficiency in CKD patients from north China, and the deficiency is dependent on eGFR. Urinary protein and serum Ca might be associated with 25(OH)D concentration. DM patients have lower 25(OH)D concentrations than non-DM patients.
很少有研究对中国慢性肾脏病(CKD)患者的维生素D缺乏情况进行调查。我们的主要目的是检测25(OH)D水平,并探究导致维生素D缺乏的可能相关因素。
2013年2月至2015年4月,本研究纳入了207名来自中国北方且未接受维生素D补充治疗的患者。我们采集血样以测定血清肌酐(Scr)、血尿素氮(BUN)、尿酸(UA)、血清磷(P)和钙(Ca)、全段甲状旁腺激素(iPTH)、白蛋白(ALB)水平,以及24小时尿蛋白(24hUPr)。通过电化学发光免疫分析法测定总25(OH)D。维生素D缺乏定义为25(OH)D < 15 ng/mL。
207名患者中,仅有20.3%的患者循环25(OH)D水平> 15 ng/mL。根据估算肾小球滤过率(eGFR)(89 - 60、59 - 45、44 - 30、29 - 15、< 15 mL/min/1.73m²)分组,25(OH)D浓度分别为11.73 ± 6.75 ng/mL、10.44 ± 6.03 ng/mL、10.05 ± 5.57 ng/mL、9.10 ± 5.00 ng/mL、7.13 ± 3.99 ng/mL(p < 0.001)。每组中25(OH)D缺乏的患病率均显著较高(70.1%、70.8%、76.5%、81.6%、91.4%,p < 0.001)。25(OH)D浓度随肾功能下降而降低。24hUPr≥3.5 g组与24hUPr < 3.5 g组之间的25(OH)D水平差异具有统计学意义。多因素线性回归分析显示,25(OH)D浓度与24hUPr和血清Ca相关。与非糖尿病(DM)患者相比,DM患者的25(OH)D浓度较低,25(OH)D缺乏的患病率较高。
本研究表明中国北方CKD患者中25(OH)D缺乏的患病率较高,且这种缺乏情况取决于eGFR。尿蛋白和血清Ca可能与25(OH)D浓度有关。DM患者的25(OH)D浓度低于非DM患者。